Everolimus

Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes Midostaurin. It is labeled for the treatment of Acute Myeloid Leukemia(AML) & Systemic Mastocytosis. Contact us for more information.

Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes Ozanimod. It is labeled for the treatment of Multiple Sclerosis & Ulcerative Colitis. Contact us for more information.

Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes Palbociclib. It is labeled for the treatment of breast cancer. Contact us for more information.

Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes Ribociclib Succinate. It is labeled for the treatment of breast cancer. Contact us for more information.

Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes Teriparatie. It is labeled for the treatment of osteoporosis. Contact us for more information.

Anticancer/Immunosuppressant

CCSB commercialized fermentation and semi-synthesis products like Tacrolimus, Everolimus, Sirolimus and Caspofungin Acetate and are in position to offer the these expertises to Semaglutide API. 

Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes tacrolimus. It belongs to immunosuppressant category. Contact us for more information.

Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes caspofungin acetate. It belongs to antifungal category. Contact us for more information.

Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes ethyl icosapentate. Contact us for more information.

Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes fluconazole. It belongs to antifungal category. Contact us for more information.

Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes ingenol mebutate. It belongs to oncology category. Contact us for more information.